Skip to main content
. 2020 Jun 19;10:9948. doi: 10.1038/s41598-020-67031-4

Table 3.

To explore the impact if CM patients treated with or without GCs have on the incidence of CM-IRIS.

Group CM-IRIS CM non-IRIS Total Incidence (%) of CM-IRIS
A 5 3 8 62.50
B 21 71 92 22.83
Total 26 74 100 26

Note: Group A: treated without GCs; Group B: treated with GCs. Adopted χ 2 test which contained a matrix of rows and columns to check the formula: χ2 = 6.021, P = 0.014.